Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice

Peptides

Volumn 29, Issue 7, 2008, Pages 1183-1190

  Wang, Yi qing ^a   Guo, Jia ^a   Wang, Sheng bin ^a   Fang, Quan ^a   He, Feng ^a   Wang, Rui ^a,b  

^a North West Normal University   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Hypothermia; Mice; Morphine; Neuropeptide FF (NPFF); Nociceptin orphanin FQ (N OFQ); Opioid; RF9

Indexed keywords

MORPHINE; NALOXONE; NEUROPEPTIDE FF; NOCICEPTIN; OPIATE; PROTEIN INHIBITOR; RF 9;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRAIN THIRD VENTRICLE; CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; HYPOTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE MEASUREMENT; THERMOREGULATION;

ADAMANTANE; ANALGESICS, OPIOID; ANIMALS; AREA UNDER CURVE; BODY TEMPERATURE REGULATION; DIPEPTIDES; DRUG INTERACTIONS; HYPOTHERMIA; KINETICS; MALE; MICE; MORPHINE; NALOXONE; OPIOID PEPTIDES; RECEPTORS, NEUROPEPTIDE;

ANIMALIA; MUS;

EID: 44649098082     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.02.016     Document Type: Article

References (45)

1. Adler M.W., Geller E.B., Rosow C.E., and Cochin J. The opioid system and temperature regulation. Annu Rev Pharmacol Toxicol 28 (1988) 429-449
2. Allard M., Zajac J.M., and Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience 49 (1992) 101-116
3. Baker A.K., and Meert T.F. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. J Pharmacol Exp Ther 302 (2002) 1253-1264
4. Boulant J.A. Hypothalamic mechanisms in thermoregulation. Fed Proc 40 (1981) 2843-2850
5. Chen X., McClatchy D.B., Geller E.B., Liu-Chen L., Tallarida R.J., and Adler M.W. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin. Brain Res 904 (2001) 252-258
6. Desprat C., and Zajac J.M. Hypothermic effects of neuropeptide FF analogues in mice. Pharmacol Biochem Behav 58 (1997) 559-563
7. 3] NPFF. Synapse 24 (1996) 282-296
8. Fang Q., Guo J., He F., Peng Y.L., Chang M., and Wang R. In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist. Peptides 27 (2006) 2207-2213
9. Fang Q., Guo J., Peng Y.L., Chang M., He F., Chen Q., et al. In vitro and in vivo studies of dansylated compounds, the putative agonists and antagonists on neuropeptide FF receptors. Peptides 27 (2006) 1297-1304
10. Fang Q., Wang Y.Q., He F., Guo J., Guo J., Chen Q., et al. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist. Regul Pept 147 (2008) 45-51
11. Frances B., Lahlou H., and Zajac J.M. Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of neuropeptide FF. Regul Pept 98 (2001) 13-18
12. Glick S.D. Hyperthermic and hypothermic effects of morphine in mice: interactions with apomorphine and pilocarpine and changes in sensitivity after caudate nucleus lesions. Arch Int Pharmacodyn 213 (1975) 264-271
13. Guerrini R., Calo' G., Bigoni R., Rizzi D., Regoli D., and Salvadori S. Structure-activity relationship of [Nphe1]NC(1-13)NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist. J Pept Res 57 (2001) 215-222
14. Higgins G.A., Grottick A.J., Ballard T.M., Richards J.G., Messer J., Takeshima H., et al. Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function. Neuropharmacology 41 (2001) 97-107
15. Jhamandas J.H., Simonin F., Bourguignon J.J., and Harris K.H. Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus. Am J Physiol-Regul Integr Comp Physiol 292 (2007) R1872-R1880
16. Lake J.R., Hammond M.V., Shaddox R.C., Hunsicker L.M., Yang H.Y., and Malin D.H. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci Lett 132 (1991) 29-32
17. Lake J.R., Hebert K.M., Payza K., Deshotel K.D., Hausam D.D., Witherspoon W.E., et al. Analog of neuropeptide FF attenuates morphine tolerance. Neurosci Lett 146 (1992) 203-206
18. Malin D.H., Lake J.R., Arcangeli K.R., Deshotel K.D., Hausam D.D., Witherspoon W.E., et al. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome. Life Sci 53 (1993) PL261-PL266
19. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
20. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol 340 (1997) 1-15
21. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., and Grandy D.K. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci Lett 214 (1996) 131-134
22. Mollereau C., Roumy M., and Zajac J.M. Opioid-modulating peptides: mechanisms of action. Curr Top Med Chem 5 (2005) 341-355
23. Panula P., Aarnisalo A.A., Wasowicz K., and Neuropeptide F.F. A mammalian neuropeptide with multiple functions. Prog Neurobiol 48 (1996) 461-487
24. Panula P., Kalso E., Nieminen M., Kontinen V.K., Brandt A., and Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res 848 (1999) 191-196
25. Price D.A., and Greenberg M.J. Structure of a molluscan cardioexcitatory neuropeptide. Science 197 (1977) 670-671
26. Quelven I., Roussin A., Burlet-Schiltz O., Gouarderes C., Tafani J.A., Mazarguil H., et al. Dissociation of pharmacological proand anti-opioid effects by neuropeptide FF analogs. Eur J Pharmacol 449 (2002) 91-98
27. Quelven I., Roussin A., and Zajac J.M. Comparison of pharmacological activities of neuropeptide FF1 and neuropeptide FF2 receptor agonists. Eur J Pharmacol 508 (2005) 107-114
28. Rawls S.M., Schroeder J.A., Ding Z., Rodriguez T., and Zaveri N. NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats. Neuropeptides 41 (2007) 239-247
29. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270 (1995) 792-794
30. Rezayat M., Ravandeh N., and Zarrindast M.R. Cholecystokinin and morphine-induced hypothermia. Eur Neuropsychopharmacol 9 (1999) 219-225
31. Romanovsky A.A. Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system. Am J Physiol Regul Integr Comp Physiol 292 (2007) R37-R46
32. Rosow C.E., Miller J.M., Pelikan E.W., and Cochin J. Opiates and thermoregulation in mice. I. Agonists. J Pharmacol Exp Ther 213 (1980) 273-283
33. Rosow C.E., Miller J.M., Poulsen-Burke J., and Cochin J. Opiates and thermoregulation in mice. II. Effects of opiate antagonists. J Pharmacol Exp Ther 220 (1982) 464-467
34. Roumy M., Garnier M., and Zajac J.M. Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones. Neurosci Lett 348 (2003) 159-162
35. Roumy M., and Zajac J.M. Neuropeptide FF, pain and analgesia. Eur J Pharmacol 345 (1998) 1-11
36. Simonin F., Schmitt M., Laulin J.P., Laboureyras E., Jhamandas J.H., MacTavish D., et al. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci USA 103 (2006) 466-471
37. Su C.F., Liu M.Y., and Lin M.T. Intraventricular morphine produces pain relief, hypothermia, hyperglycaemia and increased prolactin and growth hormone levels in patients with cancer pain. J Neurol 235 (1987) 105-108
38. Ulugol A., Dost T., Dokmeci D., Akpolat M., Karadag C.H., and Dokmeci I. Involvement of NMDA receptors and nitric oxide in the thermoregulatory effect of morphine in mice. J Neural Transm 107 (2000) 515-521
39. Varty G.B., Hyde L.A., Hodgson R.A., Lu S.X., McCool M.F., Kazdoba T.M., et al. Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species. Psychopharmacology (Berlin) 182 (2005) 132-143
40. Waldhoer M., Bartlett S.E., and Whistler J.L. Opioid receptors. Annu Rev Biochem 73 (2004) 953-990
41. Wheelahan J.M., Leslie K., and Silbert B.S. Epidural fentanyl reduces the shivering threshold during epidural lidocaine anesthesia. Anesth Analg 87 (1998) 587-590
42. Yakimova K.S., and Pierau F.K. Nociceptin/orphanin FQ: effects on thermoregulation in rats. Methods Find Exp Clin Pharmacol 21 (1999) 345-352
43. Yang H.Y., Fratta W., Majane E.A., and Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82 (1985) 7757-7761
44. Zarrindast M.R., Vahedy A., Heidari M.R., and Ghazi-Hkonsari M. On the mechanism(s) of morphine-induced hypothermia. J Psychopharmacol 8 (1994) 222-226
45. Zajac J.M., Latapie J.P., and Frances B. Opposing interplay between Neuropeptide FF and nitric oxide in antinociception and hypothermia. Peptides 21 (2000) 1209-1213